Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04557618 · ClinicalTrials.gov registry record · NA
Auricular VNS Following Subarachnoid Hemorrhage
A NA study of Subarachnoid Hemorrhage, sponsored by Anna Huguenard.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT04557618: Recruiting NA study of Subarachnoid Hemorrhage, sponsored by Anna Huguenard.
NCT04557618 is a NA study of Subarachnoid Hemorrhage that is actively recruiting participants, run by Anna Huguenard. The registered enrollment target is 50 participants, below the 3,585-participant average among 21 other Subarachnoid Hemorrhage trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04557618, a NA study of Subarachnoid Hemorrhage, is actively recruiting participants, sponsored by Anna Huguenard.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will evaluate whether non-invasive auricular vagal nerve stimulation lowers inflammatory markers, and improves outcomes following spontaneous subarachnoid hemorrhage.
Primary Outcome
TNF alpha from blood draw
Conditions Studied
Interventions
- DEVICE Auricular Vagus Nerve Stimulation
- DEVICE Sham Auricular Vagus nerve Stimulation
Study Locations (1)
Missouri
- Washington University School of Medicine - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2021-01-05 |
| Est. Completion | 2028-12 |
| Phase | NA |
What NCT04557618 shows while recruiting
NCT04557618 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 3,585-participant average among 21 other Subarachnoid Hemorrhage trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Subarachnoid Hemorrhage appearing as the primary indexed condition, and to 2 interventions - of which Auricular Vagus Nerve Stimulation is the first listed.
NCT04557618 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT04557618 about?
NCT04557618 is a clinical study titled "Auricular VNS Following Subarachnoid Hemorrhage". This study will evaluate whether non-invasive auricular vagal nerve stimulation lowers inflammatory markers, and improves outcomes following spontaneous subarachnoid hemorrhage.
What is the current status of trial NCT04557618?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2021-01-05. Estimated completion is 2028-12.
What conditions does trial NCT04557618 study?
This clinical trial studies the following conditions: Subarachnoid Hemorrhage.
What interventions are being tested in trial NCT04557618?
The interventions under investigation include: Auricular Vagus Nerve Stimulation (DEVICE), Sham Auricular Vagus nerve Stimulation (DEVICE).
Who is sponsoring clinical trial NCT04557618?
This trial is sponsored by Anna Huguenard, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04557618 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Subarachnoid Hemorrhage
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04557618's enrollment target sits among peer trials
50 14th of 21 higher than 5 of 21 other Subarachnoid Hemorrhage trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Subarachnoid Hemorrhage trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
AFFECT Study for Patients With Intraventricular Hemorrhage, Subarachnoid Hemorrhage, Subdural Hematoma, and Ventriculitis
RECRUITING · NA
-
Impact of NMES and HPRO on Recovery After SAH- Pilot Study
RECRUITING · NA
-
Lumbar Drain vs Extraventricular Drain to Prevent Vasospasm in Subarachnoid Hemorrhage
RECRUITING · NA
-
Cerebral Perfusion Pressure (CPP) Management Information Feedback and Nursing
COMPLETED · NA
-
Early Intensive Physical Therapy in Subarachnoid Hemorrhage
COMPLETED · NA
-
Hyperpolarized 13C-pyruvate Metabolic MRI With Traumatic Brain Injury
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI